Placebo-controlled study demonstrates significant and sustained improvements in endothelial function, arterial flexibility, and systolic blood pressure in adults aged 40+ NEW YORK, Feb. 19, 2026 /PRNewswire/ — NOVOS, a longevity-focused biotechnology company developing science-backed…